marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
OptimizeRx Corporation Balance Sheet 2011-2024 | OPRX
Annual Balance Sheet OptimizeRx Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
20.6 M | -18 M | -84.4 M | -10.1 M | -18.3 M | -8.91 M | -5.12 M | -7.03 M | -8.21 M | -3.45 M | -1.12 M | -284 K | -959 K |
Long Term Debt |
34.2 M | 145 K | 237 K | 326 K | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
222 K | 89.9 K | 91 K | 123 K | 115 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 5.67 M | 2.36 M | - | - | - | - | - | - | - |
Total Current Liabilities |
17.9 M | 8.4 M | 9.37 M | 10 M | 6.11 M | 4.23 M | 3.54 M | 3.67 M | 3.37 M | 2.42 M | 2.28 M | 680 K | 1.3 M |
Total Liabilities |
56.8 M | 8.54 M | 9.61 M | 10.4 M | 11.8 M | 6.6 M | 3.54 M | 3.67 M | 3.37 M | 2.42 M | 1.97 M | 680 K | 1.3 M |
Deferred Revenue |
172 K | 164 K | 1.39 M | 286 K | 580 K | 611 K | 507 K | 387 K | 227 K | 120 K | 4.25 K | 49.3 K | 331 K |
Retained Earnings |
-64.3 M | -46.7 M | -35.3 M | -35.6 M | -33.4 M | -30.3 M | -30.4 M | -28.3 M | -26.7 M | -26.1 M | -24.6 M | -24.7 M | -24.4 M |
Total Assets |
183 M | 135 M | 141 M | 60.3 M | 56.6 M | 25.1 M | 9.76 M | 11.5 M | 12.3 M | 7.03 M | 4.01 M | 2.18 M | 2.89 M |
Cash and Cash Equivalents |
13.9 M | 18.2 M | 84.7 M | 10.5 M | 18.9 M | 8.91 M | 5.12 M | 7.03 M | 8.21 M | 3.45 M | 1.12 M | 284 K | 959 K |
Book Value |
127 M | 126 M | 131 M | 50 M | 44.9 M | 18.5 M | 6.22 M | 7.81 M | 8.94 M | 4.61 M | 2.04 M | 1.5 M | 1.59 M |
Total Shareholders Equity |
127 M | 126 M | 131 M | 50 M | 44.9 M | 18.5 M | 6.22 M | 7.81 M | 8.94 M | 4.61 M | 1.67 M | 1.4 M | 1.59 M |
All numbers in USD currency
Quarterly Balance Sheet OptimizeRx Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
33.3 M | 32.3 M | 32.4 M | 34.2 M | 5.8 K | 3.5 K | 123 K | 145 K | 167 K | 190 K | 213 K | 237 K | 261 K | 283 K | 305 K | 326 K | 326 K | 326 K | 326 K | 449 K | 449 K | 449 K | 449 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 M | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | 261 K | 283 K | 305 K | 326 K | 357 K | 326 K | 326 K | 5.67 M | 5.67 M | 5.67 M | 5.67 M | 2.36 M | 2.36 M | 2.36 M | 2.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
50.7 M | 51.9 M | 53.8 M | 56.8 M | 7.82 M | 5.51 M | 7.73 M | 8.54 M | 6.3 M | 6.63 M | 7.09 M | 9.61 M | 7.83 M | 6.95 M | 5.74 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 11.8 M | 11.8 M | 11.8 M | 11.8 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 3.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.3 M | 739 K | 1.86 M | - |
Deferred Revenue |
786 K | 1.05 M | 904 K | 172 K | 188 K | 452 K | 735 K | 164 K | 673 K | 1.04 M | 1.29 M | 1.39 M | 348 K | 320 K | 448 K | 286 K | 286 K | 286 K | 286 K | 580 K | 580 K | 580 K | 580 K | 611 K | 611 K | 611 K | 611 K | 507 K | 507 K | 507 K | 507 K | 387 K | 387 K | 387 K | 387 K | 227 K | 227 K | 227 K | 227 K | 120 K | 120 K | 120 K | 120 K | 226 K | 4.25 K | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-84.3 M | -75.2 M | -71.2 M | -64.3 M | -60.1 M | -57.3 M | -53.1 M | -46.7 M | -46.4 M | -42.9 M | -39 M | -35.3 M | -35.9 M | -35.9 M | -36.3 M | -35.6 M | -35.6 M | -35.6 M | -35.6 M | -33.4 M | -33.4 M | -33.4 M | -33.4 M | -30.3 M | -30.3 M | -30.3 M | -30.3 M | -30.4 M | -30.4 M | -30.4 M | -30.4 M | -28.3 M | -28.3 M | -28.3 M | -28.3 M | -26.7 M | -26.7 M | -26.7 M | -26.7 M | -26.1 M | -26.1 M | -26.1 M | -26.1 M | -25.1 M | -24.6 M | -24.6 M | -24.6 M | -24.8 M | -24.7 M | -24.7 M | -24.7 M | -24.4 M | -24.4 M | -24.4 M | -24.4 M |
Total Assets |
165 M | 173 M | 176 M | 183 M | 124 M | 121 M | 132 M | 135 M | 136 M | 147 M | 138 M | 141 M | 135 M | 132 M | 128 M | 60.3 M | 60.3 M | 60.3 M | 60.3 M | 56.6 M | 56.6 M | 56.6 M | 56.6 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | 9.76 M | 9.76 M | 9.76 M | 9.76 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 7.03 M | 7.03 M | 7.03 M | 7.03 M | 3.95 M | 4.01 M | 4.01 M | 4.01 M | 2.18 M | 2.18 M | 2.18 M | 2.18 M | 2.89 M | 2.89 M | 2.89 M | 2.89 M |
Cash and Cash Equivalents |
16.1 M | 15 M | 15.2 M | 13.9 M | 9.92 M | 9.81 M | 16.4 M | 18.2 M | 41.3 M | 87.4 M | 89 M | 84.7 M | 85.1 M | 83.9 M | 82.3 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 18.9 M | 18.9 M | 18.9 M | 18.9 M | 8.91 M | 8.91 M | 8.91 M | 8.91 M | 5.12 M | 5.12 M | 5.12 M | 5.12 M | 7.03 M | 7.03 M | 7.03 M | 7.03 M | 8.21 M | 8.21 M | 8.21 M | 8.21 M | 3.45 M | 3.45 M | 3.45 M | 3.45 M | 1.12 M | 1.12 M | 1.12 M | 1.12 M | 284 K | 284 K | 284 K | 284 K | 959 K | 959 K | 959 K | 959 K |
Book Value |
114 M | 121 M | 123 M | 127 M | 116 M | 116 M | 124 M | 126 M | 130 M | 141 M | 131 M | 131 M | 127 M | 125 M | 122 M | 50 M | 50 M | 50 M | 50 M | 44.9 M | 44.9 M | 44.9 M | 44.9 M | 18.5 M | 18.5 M | 18.5 M | 18.5 M | 6.22 M | 9.76 M | 9.76 M | 9.76 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 7.03 M | 7.03 M | 7.03 M | 7.03 M | 3.95 M | 4.01 M | 4.01 M | 4.01 M | 2.18 M | 2.18 M | 2.18 M | 2.18 M | 1.59 M | 2.15 M | 1.03 M | 2.89 M |
Total Shareholders Equity |
114 M | 121 M | 123 M | 127 M | 116 M | 116 M | 124 M | 126 M | 130 M | 141 M | 131 M | 131 M | 127 M | 125 M | 122 M | 50 M | 50 M | 50 M | 50 M | 44.9 M | 44.9 M | 44.9 M | 44.9 M | 18.5 M | 18.5 M | 18.5 M | 18.5 M | 6.22 M | 6.22 M | 6.22 M | 6.22 M | 7.81 M | 7.81 M | 7.81 M | 7.81 M | 8.94 M | 8.94 M | 8.94 M | 8.94 M | 4.61 M | 4.61 M | 4.61 M | 4.61 M | 1.67 M | 2.04 M | 2.04 M | 2.04 M | 1.4 M | 1.5 M | 1.5 M | 1.5 M | 1.59 M | 1.59 M | 1.59 M | 1.59 M |
All numbers in USD currency